StockData
PetMed Express Inc logo

PetMed Express Inc (PETS) stock

PETSNasdaqRetail-Drug Stores and Proprietary StoresFiscal year ends March 31
Financials through Q1 FY2027, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 7/3068% below fair value
$0.90+0.00 (+0.20%)

Close on Nov 17, 2026Market cap $19.50MP/E –Yield 0.00%

PetMed Express operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

PetMed Express's operating income for the twelve months ending Jun 30, 2026 was -$30.77M. For fiscal 2026 it was -$58.67M. The highest annual figure on record is $52.14M in fiscal 2018.

Annual operating income

PeriodPeriod endValueChange
FY2026Mar 31, 2026-$58.67M–
FY2025Mar 31, 2025-$1.53M–
FY2024Mar 31, 2024-$8.16M-234.9%
FY2023Mar 31, 2023$6.05M-75.1%
FY2022Mar 31, 2022$24.29M-20.4%
FY2021Mar 31, 2021$30.53M-1.4%
FY2020Mar 31, 2020$30.98M-32.9%
FY2019Mar 31, 2019$46.17M-11.4%
FY2018Mar 31, 2018$52.14M+39.1%
FY2017Mar 31, 2017$37.48M+15.7%
FY2016Mar 31, 2016$32.39M+17.3%
FY2015Mar 31, 2015$27.61M-2.1%
FY2014Mar 31, 2014$28.22M+4.5%
FY2013Mar 31, 2013$27.01M+3.8%
FY2012Mar 31, 2012$26.02M-21.2%
FY2011Mar 31, 2011$33.02M-18.5%
FY2010Mar 31, 2010$40.54M–

Quarterly operating income

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q1 FY2027CQ2 2026Jun 30, 2026-$6.23M–
Q4 FY2026CQ1 2026Mar 31, 2026-$5.69M–
Q3 FY2026CQ4 2025Dec 31, 2025-$10.47M–
Q2 FY2026CQ3 2025Sep 30, 2025-$8.38M-1612.6%
Q1 FY2026CQ2 2025Jun 30, 2025-$34.13M-878.2%
Q4 FY2025CQ1 2025Mar 31, 2025-$6.02M–
Q3 FY2025CQ4 2024Dec 31, 2024-$450.00K–
Q2 FY2025CQ3 2024Sep 30, 2024$554.00K-36.7%
Q1 FY2025CQ2 2024Jun 30, 2024$4.39M–
Q4 FY2024CQ1 2024Mar 31, 2024-$3.84M–
Q3 FY2024CQ4 2023Dec 31, 2023-$3.07M–
Q2 FY2024CQ3 2023Sep 30, 2023$875.00K-76.5%
Q1 FY2024CQ2 2023Jun 30, 2023-$2.13M-164.3%
Q4 FY2023CQ1 2023Mar 31, 2023-$212.00K-103.0%
Q3 FY2023CQ4 2022Dec 31, 2022-$769.00K-114.9%
Q2 FY2023CQ3 2022Sep 30, 2022$3.72M-54.0%
Q1 FY2023CQ2 2022Jun 30, 2022$3.31M-38.9%
Q4 FY2022CQ1 2022Mar 31, 2022$7.06M-15.9%
Q3 FY2022CQ4 2021Dec 31, 2021$5.15M-44.6%
Q2 FY2022CQ3 2021Sep 30, 2021$8.09M-22.8%
Q1 FY2022CQ2 2021Jun 30, 2021$5.42M-42.6%
Q4 FY2021CQ1 2021Mar 31, 2021$8.39M-1.5%
Q3 FY2021CQ4 2020Dec 31, 2020$9.29M+17.2%
Q2 FY2021CQ3 2020Sep 30, 2020$10.47M+25.1%
Q1 FY2021CQ2 2020Jun 30, 2020$9.44M+53.2%
Q4 FY2020CQ1 2020Mar 31, 2020$8.51M+9.1%
Q3 FY2020CQ4 2019Dec 31, 2019$7.93M-15.7%
Q2 FY2020CQ3 2019Sep 30, 2019$8.37M-36.6%
Q1 FY2020CQ2 2019Jun 30, 2019$6.16M-60.9%
Q4 FY2019CQ1 2019Mar 31, 2019$7.80M-44.3%
Q3 FY2019CQ4 2018Dec 31, 2018$9.41M-17.9%
Q2 FY2019CQ3 2018Sep 30, 2018$13.20M+7.8%
Q1 FY2019CQ2 2018Jun 30, 2018$15.76M+9.3%
Q4 FY2018CQ1 2018Mar 31, 2018$14.00M+19.7%
Q3 FY2018CQ4 2017Dec 31, 2017$11.47M+49.8%
Q2 FY2018CQ3 2017Sep 30, 2017$12.25M+58.4%
Q1 FY2018CQ2 2017Jun 30, 2017$14.42M–
Q4 FY2017CQ1 2017Mar 31, 2017$11.70M–
Q3 FY2017CQ4 2016Dec 31, 2016$7.66M–
Q2 FY2017CQ3 2016Sep 30, 2016$7.73M–

More PetMed Express figures

See a number that looks wrong?